US Patent Issued to Allogene Therapeutics, Les Laboratoires Servier on March 24 for "Methods and compositions for dosing of allogeneic chimeric antigen receptor T cells" (American, French Inventors)

ALEXANDRIA, Va., March 24 -- United States Patent no. 12,583,905, issued on March 24, was assigned to Allogene Therapeutics Inc. (South San Francisco, Calif.) and Les Laboratoires Servier (Suresnes, France).

"Methods and compositions for dosing of allogeneic chimeric antigen receptor T cells" was invented by Cyril Alkis Konto (San Francisco) and Amina Zinai (Paris).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure concerns dosages for the treatment of human patients susceptible to or diagnosed with a disease, such as cancer. Provided are methods for administering chimeric antigen receptor (CAR)-T cells. Also provided are compositions and articles of manufacture for use in the methods."

Th...